Using PCNA, we found a significantly lower number of marked cells in patients with ALS than in controls: 4 ± 1.41 cells/500 μm2 in controls vs 0.94 ± 0.72 cells/500 μm2 in ALS patients, (p < 0.01). This evidence concerns the gene PCNA and amyotrophic lateral sclerosis.